{"id":"W4403733680","doi":"10.2147/jaa.s468068","title":"Disease Burden and Access to Biologic Therapy in Patients with Severe Asthma, 2017–2022: An Analysis of the International Severe Asthma Registry","year":2024,"lang":"en","type":"article","venue":"Journal of Asthma and Allergy","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"Efficacy and Mechanism Evaluation Programme; Sanofi Genzyme; Pfizer; AKL Research and Development; Grifols; Mylan; AstraZeneca; CSL Behring; Sanofi; Regeneron Pharmaceuticals; Teva Pharmaceutical Industries; Singapore General Hospital; Amgen","keywords":"Medicine; Asthma; Disease; Intensive care medicine; Disease control; Physical therapy; Pediatrics; Internal medicine; Environmental health","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001774189,0.0001783368,0.0003846297,0.0004362274,0.00005409063,0.00009643559,0.0002714588,0.00006532553,0.0001831706],"category_scores_gemma":[0.00005563411,0.00009499263,0.0001660534,0.0004913756,0.00009962159,0.0003014503,0.0001098884,0.0002126438,6.638101e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004340995,"about_ca_system_score_gemma":0.0002052671,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002993826,"about_ca_topic_score_gemma":0.00006769395,"domain_scores_codex":[0.9986535,0.00007805945,0.0003896017,0.0002575955,0.0004646835,0.0001566062],"domain_scores_gemma":[0.9989766,0.00004577366,0.0002220859,0.0002186311,0.0002186759,0.0003182605],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004721624,0.0004764388,0.8859003,0.0000850175,0.001838705,0.000441992,0.0006570662,0.002120194,0.000307758,0.00006754983,0.001737327,0.1016461],"study_design_scores_gemma":[0.001420516,0.001006765,0.9745836,0.0003445762,0.00008385745,0.0000593568,0.0003653769,0.0005126578,0.00001467202,0.00003266734,0.02144728,0.0001286996],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950634,0.002129635,0.00002611156,0.002255935,0.0001630922,0.0001531711,0.00006834745,0.000006738975,0.000133616],"genre_scores_gemma":[0.99847,0.0004436366,0.00005921196,0.0005001264,0.0002369647,0.000003455716,0.00001998436,0.00001403556,0.0002525791],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1015174,"threshold_uncertainty_score":0.3873687,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01221580215110849,"score_gpt":0.2769490915455624,"score_spread":0.2647332893944539,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}